Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1971776rdf:typepubmed:Citationlld:pubmed
pubmed-article:1971776lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1971776lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:1971776lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:1971776lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:1971776lifeskim:mentionsumls-concept:C0700502lld:lifeskim
pubmed-article:1971776lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:1971776lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:1971776lifeskim:mentionsumls-concept:C0150312lld:lifeskim
pubmed-article:1971776pubmed:issue2lld:pubmed
pubmed-article:1971776pubmed:dateCreated1990-7-11lld:pubmed
pubmed-article:1971776pubmed:abstractTextA case report of three patients with primary hypothyroidism who had potent TSH-binding inhibitor immunoglobulins (TBII) and both thyroid stimulating (TSAb) and thyroid stimulation-blocking antibodies (TSBAb) has been described. Two patients displayed symptoms and signs indistinguishable from those in primary myxoedema (cases 1 and 2), and another patient had a history of Graves' disease (case 3). TBII, TSAb and TSBAb activities were 90.0, 1084.2 and 94.5% in case 1, 91.5, 826.6 and 95.8% in case 2, 76.0, 230.0 and 95.0% in case 3, respectively (normal range, less than 11.0%, less than 145.0 and less than 22.0%, respectively. The results indicate that both stimulating and blocking types of TSH-receptor antibodies exist in these patients. The possible mechanism whereby hypothyroidism developed has been discussed.lld:pubmed
pubmed-article:1971776pubmed:languageenglld:pubmed
pubmed-article:1971776pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1971776pubmed:citationSubsetIMlld:pubmed
pubmed-article:1971776pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1971776pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1971776pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1971776pubmed:statusMEDLINElld:pubmed
pubmed-article:1971776pubmed:monthFeblld:pubmed
pubmed-article:1971776pubmed:issn0300-0664lld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:TakedaKKlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:KonishiJJlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:KasagiKKlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:MALZS SSSlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:KumaKKlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:TakamatsuJJlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:MisakiTTlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:HidakaAAlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:HatabuHHlld:pubmed
pubmed-article:1971776pubmed:authorpubmed-author:GoshiKKlld:pubmed
pubmed-article:1971776pubmed:issnTypePrintlld:pubmed
pubmed-article:1971776pubmed:volume32lld:pubmed
pubmed-article:1971776pubmed:ownerNLMlld:pubmed
pubmed-article:1971776pubmed:authorsCompleteYlld:pubmed
pubmed-article:1971776pubmed:pagination253-60lld:pubmed
pubmed-article:1971776pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:meshHeadingpubmed-meshheading:1971776-...lld:pubmed
pubmed-article:1971776pubmed:year1990lld:pubmed
pubmed-article:1971776pubmed:articleTitlePresence of both stimulating and blocking types of TSH-receptor antibodies in sera from three patients with primary hypothyroidism.lld:pubmed
pubmed-article:1971776pubmed:affiliationDepartment of Nuclear Medicine, Kyoto University, Japan.lld:pubmed
pubmed-article:1971776pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1971776pubmed:publicationTypeCase Reportslld:pubmed